FindTrial
Sign In

Description of the clinical characteristics of patients with inflammatory bowel diseases in public hospitals at northeastern Brazil

Characterization of the clinical-epidemiological profile on Inflammatory Bowel Disease in a prospective cohort at referral outpatient clinic unit in some States in the Northeast of Brazil - : Inflammatory Bowel Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-6wkrrd
Enrollment
Unknown
Registered
2020-04-29
Start date
2020-03-19
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn Disease

Interventions

The proposed study is a cohort of the followed up patients in a referral service for this disease at the main health units.The patients will be included in the study at the moment of being attended at
Other
E05.318.308.980

Sponsors

Instituto Autoimune
Lead Sponsor
Universidade Federal de Pernambuco
Collaborator

Eligibility

Age
1 Years to No maximum

Inclusion criteria

Inclusion criteria: Individuals diagnosed with Crohn's disease, ulcerative colitis or colitis undetermined, proven by clinical, radiological, endoscopic and ; or histopathological tests, which maintained regular follow-up at the outpatient inflammatory bowel disease of the Gastroenterology service in the hospitals involved in the project.

Exclusion criteria

Exclusion criteria: Absence of criteria for definitive diagnosis.

Design outcomes

Primary

MeasureTime frame
It is expected to improve the understanding of this disease, its impacts on the affected population and to contribute for the improvement of care provided to these patients in the Public Health System (SUS) and supplementary.—

Secondary

MeasureTime frame
Secondary denoument are not expected.—

Countries

Brazil

Contacts

Public ContactCarlos Antunes de Brito

Instituto Autoimune

cbrito@gmail.com+55 081 991277732

Outcome results

None listed

Source: REBEC (via WHO ICTRP)